SONYA BROWN-GIBSON: Open Payments
NPI 1093294407 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$91 in 5 payments from 4 companies in 2025. Trend: 2023 $70 · 2024 $69 · 2025 $91
Food & beverage: $91
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Auvelity, Epclusa, Ozempic, PIFELTRO.
Industry payments across MS — which companies pay providers there.
